{"entity":{"type":"insider","cik":"0001744425","url":"/insider/0001744425","json_url":"/insider/0001744425.json","name":"Esposito Pamela","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":41,"n_filings":21,"first":"2020-09-01","last":"2026-03-20","span_basis":"filed_date"},"name_variants":[{"name":"Esposito Pamela","source":"filing","n_filings":21,"first_seen":"2020-09-01","last_seen":"2026-03-20"}],"transactions":[{"id":6016892,"accession":"0001193125-26-118032","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001193125-26-118032","line_url":"/filing/0001193125-26-118032","is_derivative":false,"issuer_cik":"0001744425","issuer_name":"Kymera Therapeutics, Inc.","issuer_ticker":"KYMR","issuer_name_source":null,"issuer_url":"/issuer/0001744425","owner_cik":"0001744425","owner_name":"Esposito Pamela","owner_display_name":"Esposito Pamela","owner_url":"/insider/0001744425","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":79.15086,"price_display":"79.15","price_state":"stated","total_value":197877.15,"total_display":"197,877.15","total_whole":"197,877","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-20","filed_date":"2026-03-20","scope":"insider","n_lines":3},{"id":5782344,"accession":"0001193125-26-061686","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001193125-26-061686","line_url":"/filing/0001193125-26-061686","is_derivative":false,"issuer_cik":"0001744425","issuer_name":"Kymera Therapeutics, Inc.","issuer_ticker":"KYMR","issuer_name_source":null,"issuer_url":"/issuer/0001744425","owner_cik":"0001744425","owner_name":"Esposito Pamela","owner_display_name":"Esposito Pamela","owner_url":"/insider/0001744425","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":87.308004,"price_display":"87.31","price_state":"stated","total_value":218270.01,"total_display":"218,270.01","total_whole":"218,270","shares_owned_after":600.0,"shares_owned_after_display":"600","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-20","filed_date":"2026-02-20","scope":"insider","n_lines":2},{"id":6228354,"accession":"0001193125-26-016934","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001193125-26-016934","line_url":"/filing/0001193125-26-016934","is_derivative":false,"issuer_cik":"0001744425","issuer_name":"Kymera Therapeutics, Inc.","issuer_ticker":"KYMR","issuer_name_source":null,"issuer_url":"/issuer/0001744425","owner_cik":"0001744425","owner_name":"Esposito Pamela","owner_display_name":"Esposito Pamela","owner_url":"/insider/0001744425","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5500.0,"shares_display":"5,500","price_per_share":67.9129309090909,"price_display":"67.91","price_state":"stated","total_value":373521.12,"total_display":"373,521.12","total_whole":"373,521","shares_owned_after":200.0,"shares_owned_after_display":"200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-20","filed_date":"2026-01-20","scope":"insider","n_lines":3},{"id":4991301,"accession":"0001193125-25-323090","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001193125-25-323090","line_url":"/filing/0001193125-25-323090","is_derivative":false,"issuer_cik":"0001744425","issuer_name":"Kymera Therapeutics, Inc.","issuer_ticker":"KYMR","issuer_name_source":null,"issuer_url":"/issuer/0001744425","owner_cik":"0001744425","owner_name":"Esposito Pamela","owner_display_name":"Esposito Pamela","owner_url":"/insider/0001744425","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27563.0,"shares_display":"27,563","price_per_share":82.15652411203425,"price_display":"82.16","price_state":"stated","total_value":2264480.2741,"total_display":"2,264,480.27","total_whole":"2,264,480","shares_owned_after":13058.0,"shares_owned_after_display":"13,058","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-17","filed_date":"2025-12-17","scope":"insider","n_lines":4},{"id":4341766,"accession":"0000950170-25-081201","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-081201","line_url":"/filing/0000950170-25-081201#line-2","is_derivative":false,"issuer_cik":"0001744425","issuer_name":"Kymera Therapeutics, Inc.","issuer_ticker":"KYMR","issuer_name_source":null,"issuer_url":"/issuer/0001744425","owner_cik":"0001744425","owner_name":"Esposito Pamela","owner_display_name":"Esposito Pamela","owner_url":"/insider/0001744425","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":49.0371,"price_display":"49.04","price_state":"stated","total_value":245185.5,"total_display":"245,185.50","total_whole":"245,186","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-03","filed_date":"2025-06-03","scope":"insider"},{"id":3113351,"accession":"0000950170-24-132401","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-132401","line_url":"/filing/0000950170-24-132401#line-2","is_derivative":false,"issuer_cik":"0001744425","issuer_name":"Kymera Therapeutics, Inc.","issuer_ticker":"KYMR","issuer_name_source":null,"issuer_url":"/issuer/0001744425","owner_cik":"0001744425","owner_name":"Esposito Pamela","owner_display_name":"Esposito Pamela","owner_url":"/insider/0001744425","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":49.0,"price_display":"49.00","price_state":"stated","total_value":122500.0,"total_display":"122,500.00","total_whole":"122,500","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-02","filed_date":"2024-12-02","scope":"insider"},{"id":2638765,"accession":"0000950170-24-107458","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000950170-24-107458","line_url":"/filing/0000950170-24-107458","is_derivative":false,"issuer_cik":"0001744425","issuer_name":"Kymera Therapeutics, Inc.","issuer_ticker":"KYMR","issuer_name_source":null,"issuer_url":"/issuer/0001744425","owner_cik":"0001744425","owner_name":"Esposito Pamela","owner_display_name":"Esposito Pamela","owner_url":"/insider/0001744425","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13500.0,"shares_display":"13,500","price_per_share":48.27893703703704,"price_display":"48.28","price_state":"stated","total_value":651765.65,"total_display":"651,765.65","total_whole":"651,766","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-17","filed_date":"2024-09-17","scope":"insider","n_lines":2},{"id":8256959,"accession":"0001104659-23-100560","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-23-100560","line_url":"/filing/0001104659-23-100560#line-4","is_derivative":false,"issuer_cik":"0001737953","issuer_name":"Replimune Group, Inc.","issuer_ticker":"REPL","issuer_name_source":null,"issuer_url":"/issuer/0001737953","owner_cik":"0001744425","owner_name":"Esposito Pamela","owner_display_name":"Esposito Pamela","owner_url":"/insider/0001744425","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":6000.0,"total_display":"6,000.00","total_whole":"6,000","shares_owned_after":263436.0,"shares_owned_after_display":"263,436","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-12","filed_date":"2023-09-13","scope":"insider"},{"id":8256952,"accession":"0001104659-23-100560","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-23-100560","line_url":"/filing/0001104659-23-100560#line-2","is_derivative":false,"issuer_cik":"0001737953","issuer_name":"Replimune Group, Inc.","issuer_ticker":"REPL","issuer_name_source":null,"issuer_url":"/issuer/0001737953","owner_cik":"0001744425","owner_name":"Esposito Pamela","owner_display_name":"Esposito Pamela","owner_url":"/insider/0001744425","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5358.0,"shares_display":"5,358","price_per_share":20.01,"price_display":"20.01","price_state":"stated","total_value":107213.58,"total_display":"107,213.58","total_whole":"107,214","shares_owned_after":263436.0,"shares_owned_after_display":"263,436","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-11","filed_date":"2023-09-13","scope":"insider"},{"id":8202905,"accession":"0001104659-23-094997","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-23-094997","line_url":"/filing/0001104659-23-094997#line-3","is_derivative":false,"issuer_cik":"0001737953","issuer_name":"Replimune Group, Inc.","issuer_ticker":"REPL","issuer_name_source":null,"issuer_url":"/issuer/0001737953","owner_cik":"0001744425","owner_name":"Esposito Pamela","owner_display_name":"Esposito Pamela","owner_url":"/insider/0001744425","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18600.0,"shares_display":"18,600","price_per_share":20.01,"price_display":"20.01","price_state":"stated","total_value":372186.0,"total_display":"372,186.00","total_whole":"372,186","shares_owned_after":263436.0,"shares_owned_after_display":"263,436","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-22","filed_date":"2023-08-24","scope":"insider"},{"id":8623052,"accession":"0001104659-23-092111","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-23-092111","line_url":"/filing/0001104659-23-092111#line-2","is_derivative":false,"issuer_cik":"0001737953","issuer_name":"Replimune Group, Inc.","issuer_ticker":"REPL","issuer_name_source":null,"issuer_url":"/issuer/0001737953","owner_cik":"0001744425","owner_name":"Esposito Pamela","owner_display_name":"Esposito Pamela","owner_url":"/insider/0001744425","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1400.0,"shares_display":"1,400","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":28000.0,"total_display":"28,000.00","total_whole":"28,000","shares_owned_after":263436.0,"shares_owned_after_display":"263,436","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-11","filed_date":"2023-08-15","scope":"insider"},{"id":8429941,"accession":"0001104659-23-080113","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-23-080113","line_url":"/filing/0001104659-23-080113","is_derivative":false,"issuer_cik":"0001737953","issuer_name":"Replimune Group, Inc.","issuer_ticker":"REPL","issuer_name_source":null,"issuer_url":"/issuer/0001737953","owner_cik":"0001744425","owner_name":"Esposito Pamela","owner_display_name":"Esposito Pamela","owner_url":"/insider/0001744425","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":21.5770365,"price_display":"21.58","price_state":"stated","total_value":431540.73,"total_display":"431,540.73","total_whole":"431,541","shares_owned_after":265513.0,"shares_owned_after_display":"265,513","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-10","filed_date":"2023-07-11","scope":"insider","n_lines":2},{"id":8253602,"accession":"0001104659-23-062372","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-062372","line_url":"/filing/0001104659-23-062372#line-1","is_derivative":false,"issuer_cik":"0001737953","issuer_name":"Replimune Group, Inc.","issuer_ticker":"REPL","issuer_name_source":null,"issuer_url":"/issuer/0001737953","owner_cik":"0001744425","owner_name":"Esposito Pamela","owner_display_name":"Esposito Pamela","owner_url":"/insider/0001744425","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5966.0,"shares_display":"5,966","price_per_share":18.05,"price_display":"18.05","price_state":"stated","total_value":107686.3,"total_display":"107,686.30","total_whole":"107,686","shares_owned_after":263436.0,"shares_owned_after_display":"263,436","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-16","filed_date":"2023-05-18","scope":"insider"},{"id":6110238,"accession":"0001104659-22-126741","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-22-126741","line_url":"/filing/0001104659-22-126741#line-2","is_derivative":false,"issuer_cik":"0001737953","issuer_name":"Replimune Group, Inc.","issuer_ticker":"REPL","issuer_name_source":null,"issuer_url":"/issuer/0001737953","owner_cik":"0001744425","owner_name":"Esposito Pamela","owner_display_name":"Esposito Pamela","owner_url":"/insider/0001744425","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":25.03,"price_display":"25.03","price_state":"stated","total_value":375450.0,"total_display":"375,450.00","total_whole":"375,450","shares_owned_after":229402.0,"shares_owned_after_display":"229,402","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-09","filed_date":"2022-12-13","scope":"insider"},{"id":6990705,"accession":"0001104659-22-062610","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-22-062610","line_url":"/filing/0001104659-22-062610#line-1","is_derivative":false,"issuer_cik":"0001737953","issuer_name":"Replimune Group, Inc.","issuer_ticker":"REPL","issuer_name_source":null,"issuer_url":"/issuer/0001737953","owner_cik":"0001744425","owner_name":"Esposito Pamela","owner_display_name":"Esposito Pamela","owner_url":"/insider/0001744425","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3507.0,"shares_display":"3,507","price_per_share":14.59,"price_display":"14.59","price_state":"stated","total_value":51167.13,"total_display":"51,167.13","total_whole":"51,167","shares_owned_after":229402.0,"shares_owned_after_display":"229,402","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-16","filed_date":"2022-05-18","scope":"insider"},{"id":4168187,"accession":"0001104659-21-101719","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-21-101719","line_url":"/filing/0001104659-21-101719#line-4","is_derivative":false,"issuer_cik":"0001737953","issuer_name":"Replimune Group, Inc.","issuer_ticker":"REPL","issuer_name_source":null,"issuer_url":"/issuer/0001737953","owner_cik":"0001744425","owner_name":"Esposito Pamela","owner_display_name":"Esposito Pamela","owner_url":"/insider/0001744425","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25800.0,"shares_display":"25,800","price_per_share":35.09,"price_display":"35.09","price_state":"stated","total_value":905322.0,"total_display":"905,322.00","total_whole":"905,322","shares_owned_after":210159.0,"shares_owned_after_display":"210,159","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-05","filed_date":"2021-08-06","scope":"insider"},{"id":4168183,"accession":"0001104659-21-101719","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-21-101719","line_url":"/filing/0001104659-21-101719#line-2","is_derivative":false,"issuer_cik":"0001737953","issuer_name":"Replimune Group, Inc.","issuer_ticker":"REPL","issuer_name_source":null,"issuer_url":"/issuer/0001737953","owner_cik":"0001744425","owner_name":"Esposito Pamela","owner_display_name":"Esposito Pamela","owner_url":"/insider/0001744425","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4200.0,"shares_display":"4,200","price_per_share":35.0,"price_display":"35.00","price_state":"stated","total_value":147000.0,"total_display":"147,000.00","total_whole":"147,000","shares_owned_after":210159.0,"shares_owned_after_display":"210,159","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-04","filed_date":"2021-08-06","scope":"insider"},{"id":4987594,"accession":"0001104659-21-095084","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-21-095084","line_url":"/filing/0001104659-21-095084#line-4","is_derivative":false,"issuer_cik":"0001737953","issuer_name":"Replimune Group, Inc.","issuer_ticker":"REPL","issuer_name_source":null,"issuer_url":"/issuer/0001737953","owner_cik":"0001744425","owner_name":"Esposito Pamela","owner_display_name":"Esposito Pamela","owner_url":"/insider/0001744425","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12538.0,"shares_display":"12,538","price_per_share":33.17,"price_display":"33.17","price_state":"stated","total_value":415885.46,"total_display":"415,885.46","total_whole":"415,885","shares_owned_after":210159.0,"shares_owned_after_display":"210,159","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-21","filed_date":"2021-07-22","scope":"insider"},{"id":4987585,"accession":"0001104659-21-095084","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-21-095084","line_url":"/filing/0001104659-21-095084#line-2","is_derivative":false,"issuer_cik":"0001737953","issuer_name":"Replimune Group, Inc.","issuer_ticker":"REPL","issuer_name_source":null,"issuer_url":"/issuer/0001737953","owner_cik":"0001744425","owner_name":"Esposito Pamela","owner_display_name":"Esposito Pamela","owner_url":"/insider/0001744425","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4862.0,"shares_display":"4,862","price_per_share":33.05,"price_display":"33.05","price_state":"stated","total_value":160689.1,"total_display":"160,689.10","total_whole":"160,689","shares_owned_after":210159.0,"shares_owned_after_display":"210,159","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-20","filed_date":"2021-07-22","scope":"insider"},{"id":4168133,"accession":"0001104659-21-093671","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-21-093671","line_url":"/filing/0001104659-21-093671#line-2","is_derivative":false,"issuer_cik":"0001737953","issuer_name":"Replimune Group, Inc.","issuer_ticker":"REPL","issuer_name_source":null,"issuer_url":"/issuer/0001737953","owner_cik":"0001744425","owner_name":"Esposito Pamela","owner_display_name":"Esposito Pamela","owner_url":"/insider/0001744425","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4600.0,"shares_display":"4,600","price_per_share":33.37,"price_display":"33.37","price_state":"stated","total_value":153502.0,"total_display":"153,502.00","total_whole":"153,502","shares_owned_after":210159.0,"shares_owned_after_display":"210,159","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-15","filed_date":"2021-07-19","scope":"insider"},{"id":9223661,"accession":"0001104659-21-093670","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-21-093670","line_url":"/filing/0001104659-21-093670","is_derivative":false,"issuer_cik":"0001737953","issuer_name":"Replimune Group, Inc.","issuer_ticker":"REPL","issuer_name_source":null,"issuer_url":"/issuer/0001737953","owner_cik":"0001744425","owner_name":"Esposito Pamela","owner_display_name":"Esposito Pamela","owner_url":"/insider/0001744425","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5727.0,"shares_display":"5,727","price_per_share":42.47009952854898,"price_display":"42.47","price_state":"stated","total_value":243226.26,"total_display":"243,226.26","total_whole":"243,226","shares_owned_after":181121.0,"shares_owned_after_display":"181,121","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-19","filed_date":"2021-07-19","scope":"insider","n_lines":2},{"id":4409703,"accession":"0001104659-21-005570","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001104659-21-005570","line_url":"/filing/0001104659-21-005570","is_derivative":false,"issuer_cik":"0001737953","issuer_name":"Replimune Group, Inc.","issuer_ticker":"REPL","issuer_name_source":null,"issuer_url":"/issuer/0001737953","owner_cik":"0001744425","owner_name":"Esposito Pamela","owner_display_name":"Esposito Pamela","owner_url":"/insider/0001744425","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5727.0,"shares_display":"5,727","price_per_share":42.47009952854898,"price_display":"42.47","price_state":"stated","total_value":243226.26,"total_display":"243,226.26","total_whole":"243,226","shares_owned_after":175994.0,"shares_owned_after_display":"175,994","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-19","filed_date":"2021-01-19","scope":"insider","n_lines":2},{"id":9223658,"accession":"0001104659-21-093670","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-21-093670","line_url":"/filing/0001104659-21-093670#line-2","is_derivative":false,"issuer_cik":"0001737953","issuer_name":"Replimune Group, Inc.","issuer_ticker":"REPL","issuer_name_source":null,"issuer_url":"/issuer/0001737953","owner_cik":"0001744425","owner_name":"Esposito Pamela","owner_display_name":"Esposito Pamela","owner_url":"/insider/0001744425","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":29273.0,"shares_display":"29,273","price_per_share":43.58,"price_display":"43.58","price_state":"stated","total_value":1275717.34,"total_display":"1,275,717.34","total_whole":"1,275,717","shares_owned_after":175994.0,"shares_owned_after_display":"175,994","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-15","filed_date":"2021-07-19","scope":"insider"},{"id":4409698,"accession":"0001104659-21-005570","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-21-005570","line_url":"/filing/0001104659-21-005570#line-4","is_derivative":false,"issuer_cik":"0001737953","issuer_name":"Replimune Group, Inc.","issuer_ticker":"REPL","issuer_name_source":null,"issuer_url":"/issuer/0001737953","owner_cik":"0001744425","owner_name":"Esposito Pamela","owner_display_name":"Esposito Pamela","owner_url":"/insider/0001744425","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":29273.0,"shares_display":"29,273","price_per_share":43.58,"price_display":"43.58","price_state":"stated","total_value":1275717.34,"total_display":"1,275,717.34","total_whole":"1,275,717","shares_owned_after":175994.0,"shares_owned_after_display":"175,994","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-15","filed_date":"2021-01-19","scope":"insider"},{"id":9223660,"accession":"0001104659-21-093670","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-093670","line_url":"/filing/0001104659-21-093670#line-1","is_derivative":false,"issuer_cik":"0001737953","issuer_name":"Replimune Group, Inc.","issuer_ticker":"REPL","issuer_name_source":null,"issuer_url":"/issuer/0001737953","owner_cik":"0001744425","owner_name":"Esposito Pamela","owner_display_name":"Esposito Pamela","owner_url":"/insider/0001744425","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":45.02,"price_display":"45.02","price_state":"stated","total_value":900400.0,"total_display":"900,400.00","total_whole":"900,400","shares_owned_after":175994.0,"shares_owned_after_display":"175,994","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-14","filed_date":"2021-07-19","scope":"insider"},{"id":4409695,"accession":"0001104659-21-005570","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-21-005570","line_url":"/filing/0001104659-21-005570#line-2","is_derivative":false,"issuer_cik":"0001737953","issuer_name":"Replimune Group, Inc.","issuer_ticker":"REPL","issuer_name_source":null,"issuer_url":"/issuer/0001737953","owner_cik":"0001744425","owner_name":"Esposito Pamela","owner_display_name":"Esposito Pamela","owner_url":"/insider/0001744425","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":45.02,"price_display":"45.02","price_state":"stated","total_value":900400.0,"total_display":"900,400.00","total_whole":"900,400","shares_owned_after":175994.0,"shares_owned_after_display":"175,994","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-14","filed_date":"2021-01-19","scope":"insider"},{"id":2806958,"accession":"0001104659-20-115710","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-20-115710","line_url":"/filing/0001104659-20-115710","is_derivative":false,"issuer_cik":"0001737953","issuer_name":"Replimune Group, Inc.","issuer_ticker":"REPL","issuer_name_source":null,"issuer_url":"/issuer/0001737953","owner_cik":"0001744425","owner_name":"Esposito Pamela","owner_display_name":"Esposito Pamela","owner_url":"/insider/0001744425","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16000.0,"shares_display":"16,000","price_per_share":32.900625,"price_display":"32.90","price_state":"stated","total_value":526410.0,"total_display":"526,410.00","total_whole":"526,410","shares_owned_after":112700.0,"shares_owned_after_display":"112,700","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-14","filed_date":"2020-10-16","scope":"insider","n_lines":2},{"id":3043593,"accession":"0001104659-20-101464","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-20-101464","line_url":"/filing/0001104659-20-101464#line-2","is_derivative":false,"issuer_cik":"0001737953","issuer_name":"Replimune Group, Inc.","issuer_ticker":"REPL","issuer_name_source":null,"issuer_url":"/issuer/0001737953","owner_cik":"0001744425","owner_name":"Esposito Pamela","owner_display_name":"Esposito Pamela","owner_url":"/insider/0001744425","role":"Officer (Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":27.05,"price_display":"27.05","price_state":"stated","total_value":135250.0,"total_display":"135,250.00","total_whole":"135,250","shares_owned_after":112700.0,"shares_owned_after_display":"112,700","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-31","filed_date":"2020-09-01","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":41,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":41,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":41},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001815442","name":"Kymera Therapeutics, Inc.","url":"/issuer/0001815442","role":"Director","n_filings":7,"first_seen":"2024-09-17","last_seen":"2026-03-20"},{"type":"issuer","type_label":"ISSUER","cik":"0001737953","name":"Replimune Group, Inc.","url":"/issuer/0001737953","role":"Officer (Chief Business Officer)","n_filings":14,"first_seen":"2020-09-01","last_seen":"2023-09-13"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001744425","retrieved_at":"2026-08-25T15:18:06+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}